just to add another opinion, one of the things i really like about my Medtronic pump is that the screen is a nice size and very bright and easy to read. i also like that i can go back and forth while plugging in info, so, for the most part, i dont make any goofy mistakes when programming it (for boluses or whatever).
and again, i will press the issue that they have unbelievable customer support and tech teams!
That sounds like a crappy deal. They give you their older pump that they no longer have a market for. Like when you go to a car dealer at the end of the year and they want to unload the older model cars to get them off their lot.
I know Insulet doesnāt give Animas users leftovers. Iām sure Tandem doesnāt do that either.
Well the ānewā sensor is simply the next version of the old sensor. Like the G5 is the next version of the G4. Why did Medtronic change the name? Because the know the old one was so horrible that they wanted to try and disassociate. So rather then call it the Enlite v3, the renamed it the Guardian 3. Rather telling. (If I am wrong and have gotten confused then I certainly welcome any corrections on this.)
My first choice in picking a pump is which CGM does it interface with. No dexcom either currently or in the works is an absolute deal killer.
i do like my dexcome as ive been with them since 2010. but willing to give the medtronic one a try. i can always go back to the dexcom if i am unhappy, etc. i wished there were more pump companies than what we do have for choices.
Hopefully, since they are giving you older technology, it is only for the time remaining on your warranty, but knowing how things work at big med tech, I would say they probably lock you in for the full four years, perhaps with an upgrade path to their premium tech.
Same with mine, who is a really smart and on-it guy usually. My guess is that for patients with not-great control and struggling, it probably is a major improvement; for those who already have tight control, probably less so, especially if the target of 120 is higher than your average anyway. So might be worth asking what, roughly, are the characteristics of the patients who like it? (I didnāt get into it too much with mine, since I knew I wasnāt going there now anyway, but Iāll ask eventually, since Iām sure it will come up again.)
I suspect the technology will get better over timeā¦ I think the primary shortcomings of the system are actually in how strictly the FDA limited itās functionality in the name of āsafetyāā¦ but my hope is that thatāll improve over time